G. C. Schild

1.9k total citations
64 papers, 1.5k citations indexed

About

G. C. Schild is a scholar working on Epidemiology, Infectious Diseases and Animal Science and Zoology. According to data from OpenAlex, G. C. Schild has authored 64 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Epidemiology, 16 papers in Infectious Diseases and 10 papers in Animal Science and Zoology. Recurrent topics in G. C. Schild's work include Influenza Virus Research Studies (41 papers), Respiratory viral infections research (19 papers) and Animal Virus Infections Studies (10 papers). G. C. Schild is often cited by papers focused on Influenza Virus Research Studies (41 papers), Respiratory viral infections research (19 papers) and Animal Virus Infections Studies (10 papers). G. C. Schild collaborates with scholars based in United Kingdom, Tanzania and Nepal. G. C. Schild's co-authors include Philip D. Minor, J. S. Oxford, John Oxford, G. I. Watson, A. W. Galbraith, Robert W. Newman, A. S. Beare, D. M. A. Evans, Jeffrey W. Almond and A H Rook and has published in prestigious journals such as Nature, The Lancet and The Journal of Immunology.

In The Last Decade

G. C. Schild

64 papers receiving 1.3k citations

Peers

G. C. Schild

EPIDE

IMMUN

CCM

M. Aymard France

J. S. Oxford United Kingdom

Barbara D. Baxter United States

Chiharu Kawakami Japan

Martine Valette France

Haakon Sjursen Norway

Émilie Frobert France

H Holzel United Kingdom

Thomas Francis United States

Wai-Ming Lee United States

M. Aymard France

G. C. Schild

822 ×0.8

EPIDE

426 ×1.2

189 ×0.7

IMMUN

191 ×0.9

307 ×1.5

CCM

Citations per year, relative to G. C. Schild G. C. Schild (= 1×) peers M. Aymard

Countries citing papers authored by G. C. Schild

Since Specialization

Citations

This map shows the geographic impact of G. C. Schild's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. C. Schild with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. C. Schild more than expected).

Fields of papers citing papers by G. C. Schild

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. C. Schild. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. C. Schild. The network helps show where G. C. Schild may publish in the future.

Co-authorship network of co-authors of G. C. Schild

This figure shows the co-authorship network connecting the top 25 collaborators of G. C. Schild. A scholar is included among the top collaborators of G. C. Schild based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. C. Schild. G. C. Schild is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Afzal, Muhammad, P. D. Minor, & G. C. Schild. (2000). Clinical safety issues of measles, mumps and rubella vaccines.. PubMed. 78(2). 199–204. 24 indexed citations

Ferguson, Michael A. J., P. D. Minor, D. I. Magrath, M. Spitz, & G. C. Schild. (1984). Antigenic Characterization of Poliovirus Type 3 Using Monoclonal Antibodies. Clinical Infectious Diseases. 6(Supplement_2). S510–S513. 4 indexed citations

Minor, Philip D., G. C. Schild, Michael A. J. Ferguson, et al.. (1982). Genetic and Antigenic Variation in Type 3 Polioviruses: Characterization of Strains by Monoclonal Antibodies and T1 Oligonucleotide Mapping. Journal of General Virology. 61(2). 167–176. 49 indexed citations

Mitchell, David M., Penny Fitzharris, R A Knight, G. C. Schild, & M L Snaith. (1982). Kinetics of specific anti-influenza antibody production by cultured lymphocytes from patients with systemic lupus erythematosus following influenza immunization.. PubMed. 49(2). 290–6. 6 indexed citations

Possee, R. D., G. C. Schild, & Nigel J. Dimmock. (1982). Studies on the Mechanism of Neutralization of Influenza Virus by Antibody: Evidence that Neutralizing Antibody (Anti-haemagglutinin) Inactivates Influenza Virus in vivo by Inhibiting Virion Transcriptase Activity. Journal of General Virology. 58(2). 373–386. 54 indexed citations

Schild, G. C. & J. S. Oxford. (1979). INHIBITORS OF INFLUENZA VIRUS REPLICATION. British Medical Bulletin. 35(1). 87–91. 8 indexed citations

Schild, G. C., et al.. (1979). EFFECT OF RUBELLA VACCINATION PROGRAMME ON SEROLOGICAL STATUS OF YOUNG ADULTS IN UNITED KINGDOM. The Lancet. 313(8128). 1224–1226. 14 indexed citations

Beare, A. S., et al.. (1978). Formation of antibody to matrix protein in experimental human influenza A virus infections. Infection and Immunity. 22(2). 322–327. 23 indexed citations

Wood, John, et al.. (1978). Reagents for single-radial-diffusion assay of the haemagglutinin antigens of A/New Jersey/8/76 (Hsw1 N1) and B/Hong Kong/8/73 strains of influenza virus. Journal of Biological Standardization. 6(1). 63–66. 4 indexed citations

10.

Seagroatt, Valerie, et al.. (1977). The use of single-radial-haemolysis for rubella antibody studies. Journal of Hygiene. 79(3). 355–364. 21 indexed citations

11.

Dowdle, Walter R. & G. C. Schild. (1976). Influenza: its antigenic variation and ecology.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 10(3). 193–5. 5 indexed citations

12.

Galbraith, A. W., G. C. Schild, C. W. Potter, & G. I. Watson. (1973). The therapeutic effect of amantadine in influenza occurring during the winter of 1971-2 assessed by double-blind study.. PubMed. 23(126). 34–7. 10 indexed citations

13.

Schild, G. C., et al.. (1972). Studies on relationships between human and porcine influenza. 1. Serological evidence of infection in swine in Great Britain with an influenza A virus antigenically like human Hong Kong-68 virus.. PubMed. 46(6). 709–19. 29 indexed citations

14.

Slepushkin, A. N., G. C. Schild, A. S. Beare, S Chinn, & D. A. J. Tyrrell. (1971). Neuraminidase and resistance to vaccination with live influenza A2 Hong Kong vaccines. Epidemiology and Infection. 69(4). 571–578. 28 indexed citations

15.

Schild, G. C., John Oxford, & C. W. Potter. (1970). Demonstration of a tumour and transplantation antigen in hamster tumours induced by an avian adenovirus (CELO). Archives of Virology. 29(1). 25–31. 11 indexed citations

16.

Galbraith, A. W., J. S. Oxford, G. C. Schild, & G. I. Watson. (1969). Study of 1-adamantanamine hydrochloride used prophylactically during the Hong Kong influenza epidemic in the family environment.. PubMed. 41(3). 677–82. 46 indexed citations

17.

Oxford, John & G. C. Schild. (1968). Immunofluorescent Studies on the Inhibition of Influenza A and B Viruses in Mammalian Cell Cultures by Amines and Ammonium Compounds. Journal of General Virology. 2(3). 377–384. 21 indexed citations

18.

Potter, C. W. & G. C. Schild. (1967). The Incidence of HI Antibody to Influenza Virus A2/Singapore/1/57 in Individuals of Blood Groups A and O. The Journal of Immunology. 98(6). 1320–1325. 15 indexed citations

19.

Schild, G. C. & C. H. Stuart‐Harris. (1967). Antibodies in children's sera for serologically different recently isolated strains of influenza viruses A2 and B.. BMJ. 4(5571). 82–85. 2 indexed citations

20.

Oxford, John & G. C. Schild. (1965). In vitro inhibition of rubella virus by 1-adamantanamine hydrochloride. Archives of Virology. 17(2). 313–329. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact